Title: temporal course of vascular healing and neoatherosclerosis after implantation of durable- or biodegradable-polymer drug-eluting stents authors: guagliumi, giulio; guagliumi, giulio; shimamura, kunihiro; sirbu, vasile; garbo, roberto; boccuzzi, giacomo; vassileva, ang elina; valsecchi, orazio; fiocca, luigi; canova, paolo; colombo, francesco; tensol rodriguez pereira, gabriel; nakamura, daisuke; attizzani, guilherme f; cereda, alberto; satogami, keisuke; de luca, leonardo; saia, francesco; capodanno, davide; nlm journal: european heart journal year: 2018 issue: 0, 1-10 ref: https://doi.Org/10.1093/eurheartj/ehy273.A2=average, age a3= majority gender, b3=date of publication.If information is provided in the future, a supplemental report will be issued.
|
This study was to compare in vivo vessel healing and na of current generation bp- or dp-des using serial optical coherence tomography (oct) assessments.Ninety patients were randomised to this study and resolute integrity drug-eluting stent was implanted in fourty-five patients in the study population.Vessels treated were lad, cx and rca.At 3 months, all randomized patients underwent angiographic and oct follow-up.The rates of covered, uncovered, uncovered and apposed struts were comparable between everolimus eluting stents and zotarolimus eluting stents, with some degree of inter-individual variability in both groups.The vast majority of uncovered struts were completely apposed to the vessel wall 85% in both groups.Clinical events reported at 3-months follow-up are myocardial infarction and target vessel revascularization.Clinical events reported at 2 year follow-up are death (non-cardiac), stroke, mi, target lesion revascularization and ischemia-driven target lesion revascularization.
|